Emergence of Gene Therapy is anticipated to open up the new avenue for Ornithine Transcarbamylase Deficiency Treatment
by The Ornithine Transcarbamylase Deficiency Treatment Market is estimated to be valued at US$ 810.4 Mn in 2023 and is expected to exhibit a CAGR of …